Download the free e-book on peptides, hormones and pharmaceuticals for longevity, health and performance here: get the e-book
The sleep article published earlier in this series made the case for why sleep is one of the highest leverage variables in any optimization protocol. This article goes deeper on the specific compounds that address sleep biology at the mechanistic level, what each one does, how they work together, and what to expect from a dedicated sleep optimization protocol.
The compounds most relevant to sleep optimization in the catalogue fall into two distinct categories. The first addresses the architecture of sleep itself, the depth, duration, and structure of the sleep cycle. The second addresses the hormonal and regulatory systems that govern when sleep occurs and how well the body transitions into and through it. Understanding both categories and how they interact is the foundation for designing a sleep protocol that actually changes the quality of the overnight window rather than simply sedating the nervous system.
Why sedation is not sleep optimization
Before going into the specific compounds it is worth establishing a distinction that shapes everything about how sleep optimization is approached in this context.
Conventional sleep aids, including benzodiazepines, Z-drugs like zolpidem, and even over-the-counter antihistamine-based sleep aids, work primarily by sedating the nervous system. They produce sleep in the sense that they reduce wakefulness, but they do so in ways that significantly impair the architecture of restorative sleep. Benzodiazepines suppress slow-wave sleep, the deep sleep phase where growth hormone is secreted and physical repair occurs. Z-drugs produce a similar architectural disruption. Alcohol, as covered in the sleep article, suppresses REM sleep and fragments sleep architecture in the second half of the night.
The compounds covered in this article work through entirely different mechanisms. They do not sedate. They support the biological systems that produce deep, architecturally intact sleep, the kind where the body actually does the repair, consolidation, and regulatory work that makes sleep worth having in the first place.
DSIP: delta sleep inducing peptide
DSIP, delta sleep inducing peptide, is one of the most directly named compounds in the optimization space. It was originally isolated from the cerebral venous blood of rabbits during slow-wave sleep, which is where the name comes from, and it has been studied for its effects on sleep architecture and cortisol regulation since its discovery in the 1970s.
DSIP works through several mechanisms that collectively support deeper and more restorative sleep.
Its primary sleep-related effect is the promotion of slow-wave sleep, the deep sleep stage where growth hormone secretion peaks, glymphatic clearance of metabolic waste from the brain occurs, and the majority of the body's physical repair work takes place. Rather than simply increasing total sleep time, DSIP appears to shift the architecture of sleep toward a higher proportion of slow-wave sleep, which is the most biologically productive phase of the sleep cycle.
DSIP also modulates cortisol secretion in alignment with the body's natural circadian rhythm. Cortisol follows a daily pattern of rising in the early morning to support waking and declining through the day and evening to allow the transition into sleep. Chronic stress, disrupted circadian rhythms, and the general demands of modern life frequently produce cortisol patterns where evening levels are too high, a state of being tired but wired that prevents both sleep onset and sleep depth. DSIP's modulation of cortisol secretion helps bring elevated evening cortisol back into alignment with the natural rhythm, addressing one of the most common physiological contributors to poor sleep quality.
Beyond its direct sleep effects, DSIP has antioxidant properties and has been studied for its effects on stress resilience and the body's response to physical and psychological stress. These broader regulatory effects make it relevant not just for sleep specifically but for the stress-sleep connection that undermines both dimensions simultaneously in people under chronic demand.
Epithalon and the pineal connection
Epithalon, covered in depth in the hallmarks of aging and longevity protocol articles in this series for its telomerase-activating properties, has a second set of applications in sleep optimization that are equally important and often underappreciated.
The pineal gland produces melatonin, the hormone that regulates circadian rhythm and signals to the body that it is time to sleep. Melatonin production by the pineal gland declines with age through a well-documented process of pineal calcification and reduced secretory capacity that is one of the most consistent age-related hormonal changes observed across populations.
This decline in pineal melatonin production is directly associated with the changes in sleep architecture that characterize aging. The difficulty falling asleep, the lighter sleep, the earlier waking, and the reduced proportion of slow-wave and REM sleep that most people experience as they age are all consistent with reduced melatonin signaling from a less functional pineal gland.
Epithalon was derived from pineal gland extract and has been studied specifically for its effects on pineal gland function and melatonin production. Research in aging animal models has shown that Epithalon treatment restores melatonin secretion patterns toward younger baselines, with associated improvements in circadian rhythm regulation and sleep architecture. This pineal restoration mechanism is distinct from simply supplementing melatonin exogenously, which replaces the hormone without addressing the declining gland function that reduced its production in the first place.
For people experiencing age-related sleep changes, Epithalon addresses the upstream pineal cause rather than the downstream melatonin symptom. The result is a more physiologically integrated restoration of circadian function rather than the blunt melatonin replacement that external supplementation provides.
The DSIP, BPC-157, and CJC-1295 combination
The combination of DSIP, BPC-157, and CJC-1295 represents one of the most comprehensive approaches to overnight recovery optimization available in the catalogue, addressing sleep architecture, physical repair, and growth hormone stimulation simultaneously during the overnight window.
The logic of this combination is worth unpacking because it illustrates how the compounds in this space are most effectively used when their mechanisms are complementary rather than redundant.
DSIP addresses the sleep architecture and cortisol regulation dimension, supporting deeper slow-wave sleep and the hormonal conditions that make the overnight window maximally restorative.
BPC-157 contributes its tissue repair, angiogenic, and anti-inflammatory properties during the overnight period when the body's repair processes are most active. The connective tissue repair, gut mucosal maintenance, and systemic anti-inflammatory effects that BPC-157 produces are all processes that occur predominantly during sleep, making the overnight window the optimal time for BPC-157 to be active in the system.
CJC-1295 is a long-acting GHRH analogue that stimulates growth hormone release in alignment with the natural overnight GH pulse. The body's primary growth hormone secretion occurs during the first few cycles of deep sleep, and CJC-1295's extended half-life ensures that the pituitary receives continuous GHRH stimulation through the night rather than the brief pulse that shorter-acting GHRH compounds produce. The combination with DSIP is particularly synergistic because DSIP's promotion of deep slow-wave sleep creates the biological conditions in which the GH pulse that CJC-1295 stimulates is most robust.
The net effect of this combination during the overnight window is deeper sleep, more growth hormone secretion during that sleep, more active tissue repair during the sleep period, and better cortisol regulation through the night. Each compound addresses a different aspect of overnight recovery and they reinforce each other in ways that make the combination more powerful than any single compound alone.
Semax and Selank as indirect sleep support
Semax and Selank, covered primarily in the cognitive health article for their nootropic properties, have indirect but meaningful effects on sleep quality that are worth including in any complete discussion of sleep optimization.
The most common reason for difficulty falling and staying asleep beyond the hormonal and architectural factors already discussed is an overactive stress response. The anxious mind that cannot quiet itself at bedtime, the replaying of the day's events, the anticipatory worry about tomorrow, are all expressions of elevated sympathetic nervous system activity and dysregulated cortisol and cortisol-related signaling that keeps the brain in a state of alertness when it should be transitioning into sleep.
Selank's modulation of GABA activity and its anxiolytic effects without sedation address the neurological hyperactivation that prevents sleep onset in people under chronic stress. Unlike benzodiazepines which produce sedation through indiscriminate GABA enhancement, Selank's more targeted modulation reduces anxiety and stress responsiveness without the architectural disruption to sleep quality that sedative compounds produce.
Semax's support for BDNF production and its effects on the brain's stress response system complement Selank's anxiolytic effects by addressing the underlying neurological dysregulation rather than just its immediate expression. For people whose sleep problems are driven primarily by stress and cognitive hyperactivation at bedtime, the Semax and Selank combination addresses the cause more effectively than any direct sleep compound.
Building a sleep optimization protocol
The compounds covered in this article address sleep through different mechanisms and at different points in the biological systems that govern sleep quality. A sleep optimization protocol can draw on any combination of them depending on which aspect of sleep is most in need of support.
For people whose primary issue is sleep depth and the reduction of slow-wave sleep that comes with age and stress, DSIP addresses this most directly. For people whose primary issue is circadian disruption and difficulty transitioning into and through the sleep cycle, Epithalon's pineal support is the most relevant intervention. For people whose primary issue is stress-driven sleep onset difficulty, Semax and Selank address the neurological cause. And for people who want to optimize the full overnight recovery window comprehensively, the DSIP, BPC-157, and CJC-1295 combination addresses sleep architecture, tissue repair, and growth hormone simultaneously.
These are not mutually exclusive. A comprehensive sleep protocol might combine Epithalon for pineal support and circadian regulation, DSIP for slow-wave sleep architecture and cortisol modulation, Selank for stress-driven sleep onset difficulty, and CJC-1295 for overnight growth hormone optimization, each addressing a different dimension of the overnight window in ways that collectively produce a qualitatively different sleep experience than any single intervention achieves alone.
The consistent theme across all of these compounds is that they work with the biology of sleep rather than overriding it. They support the systems that produce restorative sleep rather than substituting sedation for the real thing. And they address the specific biological dimensions of sleep that decline with age and stress in ways that the natural sleep architecture requires to be restored rather than replaced.
This content is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before making any changes to your health regimen. For more information visit www.peakformrx.health